The aim of GFB is to become an investors platform focused in biotech companies. GFB participates in biotech start-ups  through Equity investment and closely collaborates with their management teams  in contributing with our knowledge and experience.
This is the Smart Money concept. In this way we generate additional value in invested companies and, therefore, higher returns.



• Identify, evaluate and select a first group of target opportunities. Initial portfolio of at least 4 companies.

• Manage and monitor invested companies. Support to management team and actively participate in strategic decisions.
• Increase investment portfolio with minimum two new investments every year.
• Guiding and influencing strategy for invested companies, looking for an optimal exit within a reasonable time.
• Increase company valuation ending up with an optimal sale, after expected returns have been met.